Skip to main content

ADVERTISEMENT

Darrel P. Francis, MA, MRCP

Original Contribution
09/15/2008
References    ABSTRACT: Background. At 30 days, it is recognized that 12-hour periprocedural abciximab infusion protects against reinfarction and the need for revascularization in percutaneous coronary intervention (PCI) in acute myocardial...
References    ABSTRACT: Background. At 30 days, it is recognized that 12-hour periprocedural abciximab infusion protects against reinfarction and the need for revascularization in percutaneous coronary intervention (PCI) in acute myocardial...
References    ABSTRACT:...
09/15/2008
Journal of Invasive Cardiology